Holter monitoring for syncope: Diagnostic yield in different patient groups and impact on device implantation

QJM: An International Journal of Medicine

Volumn 100, Issue 12, 2007, Pages 771-777

  Kuhne M ^a   Schaer, B ^a   Moulay, N ^a   Sticherling, C ^a   Osswald, S ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIAC AGENT; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SOTALOL; VERAPAMIL;

ADULT; AGE; AGED; ARTIFICIAL HEART PACEMAKER; DEVICE; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; GENDER; HEART DISEASE; HEART EJECTION FRACTION; HOLTER MONITORING; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL RECORD REVIEW; PREDICTION; PRIORITY JOURNAL; REVIEW; SYNCOPE;

EID: 37549010696     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcm104     Document Type: Review

References (23)

1. Kapoor WN. Current evaluation and management of syncope. Circulation 2002; 106:1606-9.
2. Soteriades ES, Evans JC, Larson MG, Chen MH, Chen L, Benjamin EJ, Levy D. Incidence and prognosis of syncope. N Engl J Med 2002; 347 878-85.
3. Linzer M, Yang EH, Estes NA III, Wang P, Vorperian VR, Kapoor WN. Diagnosing syncope. Part 1: Value of history, physical examination, and electrocardiography. Clinical Efficacy Assessment Project of the American College of Physicians. Ann Intern Med 1997; 126 989-96.
4. Linzer M, Yang EH, Estes NA III, Wang P, Vorperian VR, Kapoor WN. Diagnosing syncope. Part 2: Unexplained syncope. Clinical Efficacy Assessment Project of the American College of Physicians. Ann Intern Med 1997; 127:76-86.
5. Benditt DG, Van Dijk JG, Sutton R, Wieling W, Lin JC, Sakaguchi S, Lu F. Syncope. Curr Probl Cardiol 2004; 29:152-229.
6. Sarasin FP, Louis-Simonet M, Carballo D, Slama S, Rajeswaran A, Metzger JT, Lovis C, Unger PF, Junod AF. Prospective evaluation of patients with syncope: A population-based study. Am J Med 2001; 111 177-184.
7. Kapoor WN. Syncope. N Engl J Med 2000; 343:1856-62.
8. Sarasin FP. Electrocardiographic monitoring in the assessment of unexplained syncope. Am J Med 2003; 115:66-7.
9. Arya A, Haghjoo M, Khosrawi A, Emkanjoo Z, Sadr-Ameli MA. Predictors of arrhythmic events during second day monitoring in patients with normal first day Holter recordings. Indian Heart J 2005; 57:241-4.
10. Seipel L. The clinical value of Holter ECG recording. Internist 2004; 45:1035-41.
11. Katritsis DG, Camm AJ. Nonsustained ventricular tachycardia: Where do we stand? Eur Heart J 2004; 25:1093-9.
12. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. for The Multicenter Unsustained Tachycardia Trial Investigators. A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease. N Engl J Med 1999; 341:1882-90.
13. Dolz Aspas R, Samperiz Legarre P, Calvo Begueria E, Toyas Miazza C, Ruiz Ruiz F, Morales Rull JL, Perez Calvo J, Ruiz Laiglesia F, Amores Ferreras M. Syncope: Many studies and few diagnoses? Rev Clin Esp 2004; 204:9-13.
14. Manolis AS, Linzer M, Estes NAM. Syncope: Current diagnostic evaluation and management. Ann Intern Med 1990; 112:850-63.
15. Brignole M, Menozzi C, Bartoletti A, Giada F, Lagi A, Ungar A, Ponassi I, Mussi C, Maggi R, Re G, Furlan R, Rovelli G, Ponzi P, Scivalles A. A new management of syncope: Prospective systematic guideline-based evaluation of patients referred urgently to general hospitals. Eur Heart J 2006; 27:76-82.
16. Brignole M, Alboni P, Benditt DG, et al. Task Force on Syncope, European Society of Cardiology. Guidelines on management (diagnosis and treatment) of syncope-update 2004. Executive Summary. Eur Heart J 2004; 25:2054-72.
17. Gibson TC, Heitzman MR. Diagnostic efficacy of 24-hour electrocardiographic monitoring for syncope. Am J Cardiol 1984; 53:1013-17.
18. Sarasin FP, Carballo D, Slama S, Louis-Simonet M. Usefulness of 24-h Holter monitoring in patients with unexplained syncope and a high likelihood of arrhythmias. Int J Cardiol 2005; 101:203-7.
19. Bass EB, Curtiss EI, Arena VC, Hanusa BH, Cecchetti A, Karpf M, Kapoor WN. The duration of Holter monitoring in patients with syncope: Is 24 hours enough? Arch Intern Med 1990; 150:1073-8.
20. Krahn AD, Klein GJ, Yee R, Skanes AC. Randomized assessment of syncope trial: Conventional diagnostic testing versus a prolonged monitoring strategy. Circulation 2001; 104:46-51.
21. Rockx MA, Hoch JS, Klein GJ, Yee R, Skanes AC, Gula LJ, Krahn AD. Is ambulatory monitoring for 'community-acquired' syncope economically attractive? A cost-effectiveness analysis of a randomized trial of external loop recorders versus Holter monitoring. Am Heart J 2005; 150:1065.
22. Wöhrle J, Kochs M. Syncope in the elderly. Z Gerontol Geriatr 2003; 36:2-9.
23. Manchanda S, Ehsanullah M. Suspected cardiac syncope in elderly patients: Use of the 12-lead electrocardiogram to select patients for holter monitoring. Gerontology 2001; 47:195-7.